Back

Investigating patient vulnerability during fluoropyrimidine-based chemotherapies in a cardio-oncology setting: a retrospective observational study

20 June 2026 (08:30 - 18:00)
Organised by: Logo
Congress Presentation Part of: Poster session (2) Stratification, Prevention and Monitoring CCO Premium Access ESC Cardio-Oncology 2026 Council of Cardio-Oncology

About the speaker

Photo
Doctor Timea Balazs

University of Debrecen, Debrecen (Hungary)

40 More presentations in this session

Presentation thumbnail
Absence of detectable cardiotoxicity with L-Annamycin despite high cumulative anthracycline exposure
Mr S. Waymack (Blacksburg, US)
Abstract Slides
Presentation thumbnail
Pre-existing cardiovascular disease at cancer diagnosis: national trends and future projections in england
Mr A. Alshahrani (Riyadh, SA)
Abstract Slides
Presentation thumbnail
Causal analysis of radiation dose to the base of the heart and overall survival in lung cancer using targeted maximum likelihood estimation
Mr B. Jiang (Manchester, GB)
Abstract Slides
Presentation thumbnail
High prevalence of embolic complications among cancer patients with non-bacterial thrombotic endocarditis
Doctor M. Merhi (Berlin, DE)
Abstract Slides
Presentation thumbnail
Cardio-oncology in breast cancer patients: descriptive data from a north african cohort
Doctor M. Elelmi (Tunis, TN) Doctor E. Bennour Ep Rabah (Tunis, TN)
Abstract Slides

Access the full session

Session thumbnail
Poster session (2)

The Event

Event poster

ESC Cardio-Oncology 2026

20 June 2026 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Severe cardiotoxicity due to fluoropyrimidines and the rol of the cardio-oncology team
31 August 2025
thumbnail
Congress Presentation
Validation of the HFA-ICOS cardio-oncology cardiovascular risk calculator in an Australian cancer cohort receiving anthracyclines and HER2 targeted therapies
20 June 2025
thumbnail
Congress Presentation
Safety of SGLT2-Inhibitors in cardio-oncology patients with heart failure undergoing cancer treatment
21 June 2025
thumbnail
Congress Presentation
First UAE experience: clinical characteristics of patients referred to a Cardio-Oncology clinic
20 June 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources